Condensed Consolidating Statement of Cash Flows
|
|
|
|
|
|
|
For the year ended December 31, 2004
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
IR-
|
|
IR-
|
Other
|
|
IR-Limited
|
In millions
|
|
Limited
|
New Jersey
|
Subsidiaries
|
|
Consolidated
|
|
Net cash provided by (used in) operating activities
|
|
$ 176.9
|
|
$ 984.3
|
|
$ (408.0)
|
|
|
$ 753.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
|
Capital expenditures
|
|
-
|
|
(38.2)
|
|
(70.4)
|
|
|
(108.6)
|
Proceeds from sale of property, plant and equipment
|
|
-
|
|
17.7
|
|
32.7
|
|
|
50.4
|
Investments and acquisitions, net of cash
|
|
-
|
|
-
|
|
(33.7)
|
|
|
(33.7)
|
Proceeds from business dispositions
|
|
-
|
|
189.0
|
|
1,224.2
|
|
|
1,413.2
|
Cash provided by or advances from equity companies
|
|
-
|
|
-
|
|
7.6
|
|
|
7.6
|
|
|
|
Net cash provided by investing activities
|
|
-
|
|
168.5
|
|
1,160.4
|
|
|
1,328.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
|
Net change in debt
|
|
-
|
|
(409.5)
|
|
(59.9)
|
|
|
(469.4)
|
Proceeds from the exercise of stock options
|
|
170.7
|
|
-
|
|
-
|
|
|
170.7
|
Dividends (paid) received
|
|
(271.3)
|
|
10.2
|
|
108.5
|
|
|
(152.6)
|
Purchase of treasury shares
|
|
-
|
|
-
|
|
(355.9)
|
|
|
(355.9)
|
|
|
|
Net cash used in financing activities
|
|
(100.6)
|
|
(399.3)
|
|
(307.3)
|
|
|
(807.2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in) provided by discontinued operations
|
-
|
|
(13.5)
|
|
32.4
|
|
|
18.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of change in fiscal year end of business
|
|
-
|
|
-
|
|
(23.8)
|
|
|
(23.8)
|
Effect of exchange rate changes on cash and
|
|
|
|
|
|
|
|
|
|
cash equivalents
|
|
-
|
|
-
|
|
16.5
|
|
|
16.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase in cash and cash equivalents
|
|
76.3
|
|
740.0
|
|
470.2
|
|
|
1,286.5
|
Cash and cash equivalents - beginning of period
|
|
160.5
|
|
104.1
|
|
152.6
|
|
|
417.2
|
|
|
|
Cash and cash equivalents - end of period
|
|
$ 236.8
|
|
$ 844.1
|
|
$ 622.8
|
|
|
$ 1,703.7
|
|
Condensed Consolidating Statement of Cash Flows
|
|
|
|
|
|
|
For the year ended December 31, 2003
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
IR-
|
|
IR-
|
Other
|
|
IR-Limited
|
In millions
|
|
Limited
|
New Jersey
|
Subsidiaries
|
|
Consolidated
|
|
Net cash provided by (used in) operating activities
|
|
$ 146.4
|
|
$ 285.6
|
|
$ (293.6)
|
|
|
$ 138.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
|
Capital expenditures
|
|
-
|
|
(20.5)
|
|
(78.8)
|
|
|
(99.3)
|
Proceeds from sale of property, plant and equipment
|
|
-
|
|
11.6
|
|
31.5
|
|
|
43.1
|
Investments and acquisitions, net of cash
|
|
(19.6)
|
|
(1.5)
|
|
(0.2)
|
|
|
(21.3)
|
Proceeds from business disposition
|
|
43.0
|
|
395.5
|
|
312.9
|
|
|
751.4
|
Proceeds from sales and maturities of
|
|
|
|
|
|
|
|
|
|
marketable securities
|
|
-
|
|
147.6
|
|
-
|
|
|
147.6
|
Cash (invested in) provided by or advances (to)
|
|
|
|
|
|
|
|
|
|
from equity companies
|
|
-
|
|
-
|
|
(0.6)
|
|
|
(0.6)
|
|
|
|
Net cash used in investing activities
|
|
23.4
|
|
532.7
|
|
264.8
|
|
|
820.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
|
Net change in debt
|
|
-
|
|
(924.2)
|
|
(15.4)
|
|
|
(939.6)
|
Proceeds from the exercise of stock options
|
|
211.1
|
|
-
|
|
-
|
|
|
211.1
|
Dividends (paid) received
|
|
(220.4)
|
|
8.0
|
|
89.2
|
|
|
(123.2)
|
|
|
|
Net cash (used in) provided by financing activities
|
|
(9.3)
|
|
(916.2)
|
|
73.8
|
|
|
(851.7)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in) provided by discontinued operations
|
-
|
|
(7.0)
|
|
28.8
|
|
|
21.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash and
|
|
|
|
|
|
|
|
|
|
cash equivalents
|
|
-
|
|
-
|
|
2.6
|
|
|
2.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase in cash and cash equivalents
|
|
160.5
|
|
(104.9)
|
|
76.4
|
|
|
132.0
|
Cash and cash equivalents - beginning of period
|
|
-
|
|
209.0
|
|
76.2
|
|
|
285.2
|
|
|
|
Cash and cash equivalents - end of period
|
|
$ 160.5
|
|
$ 104.1
|
|
$ 152.6
|
|
|
$ 417.2
|
|
